0001179110-14-016211.txt : 20141105 0001179110-14-016211.hdr.sgml : 20141105 20141105200644 ACCESSION NUMBER: 0001179110-14-016211 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141103 FILED AS OF DATE: 20141105 DATE AS OF CHANGE: 20141105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alton Gregg H CENTRAL INDEX KEY: 0001334682 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 141198450 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0306 4 2014-11-03 0 0000882095 GILEAD SCIENCES INC GILD 0001334682 Alton Gregg H GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 EVP, Corp & Med Affairs Common Stock 2014-11-03 4 M 0 31000 23.755 A 151694 D Common Stock 2014-11-03 4 S 0 19658 109.8943 D 132036 D Common Stock 2014-11-03 4 S 0 3350 110.4528 D 128686 D Common Stock 2014-11-03 4 S 0 6877 111.8932 D 121809 D Common Stock 2014-11-03 4 S 0 1115 112.4472 D 120694 D Common Stock 2014-11-03 4 S 0 1100 109.8556 D 119594 D Common Stock 2014-11-03 4 S 0 300 110.4367 D 119294 D Common Stock 2014-11-03 4 S 0 600 112.0367 D 118694 D Non-Qualified Stock Option (right to buy) 23.755 2014-11-03 4 M 0 31000 0 D 2020-01-28 Common Stock 31000 42367 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. Sale prices reported for the transactions reported here range from $109.2976 to $110.2971. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $110.2976 to $111.25. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $111.34 to $112.32. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $112.40 to $112.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $109.29 to $110.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $110.31 to $110.58. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $111.66 to $112.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. /s/ Gregg H. Alton 2014-11-05